Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
219 participants
INTERVENTIONAL
2022-11-29
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Stress Management for HIV+ Drug Abusers
NCT00722644
Reducing Drug Use in Justice-Involved Emerging Adults
NCT05834881
Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System
NCT02672150
HIV and HCV Intervention In Drug Treatment Settings - 1
NCT00102349
Leveraging Implementation Science to Increase Access to Trauma Treatment for Incarcerated Drug Users
NCT04007666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the first study phase, conducted from 2020-21, the investigators analyzed Wisconsin Medicaid data to characterize the baseline level of outpatient care utilization for adults during their first 6 months after release from prison, and conducted formative research necessary to adapt an existing transitional care intervention, called C-TraC, to support individuals leaving prison.
The current project aims to enroll participants in a pilot implementation study to test the feasibility and acceptability of the adapted intervention in a criminal justice setting, which has been given the name "CJC-TraC."
Participants will be enrolled from one of two institutions:
* men from Oakhill Correctional Institute (OCI)
* women from the Wisconsin Women's Correctional System (WWCS)
Primary Objectives: To evaluate the feasibility and acceptability of CJC-TraC when implemented in a state prison system.
Secondary Objectives: To gather preliminary evidence describing the effectiveness of CJC-TraC for improving the rate of outpatient care utilization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CJC-TraC Intervention
Incarcerated individuals with HIV, hepatitis C, or substance use disorder readying for release will enroll in the CJC-TraC intervention intended to assist in transitioning their health care.
CJC-TraC
CJC-TraC utilizes a nurse case manager (NCM) to coordinate the participant's transitional care through release from a correctional facility. The NCM will visit either in person or via telehealth with the participant up to 4 times while incarcerated, and up to 4 times after release.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CJC-TraC
CJC-TraC utilizes a nurse case manager (NCM) to coordinate the participant's transitional care through release from a correctional facility. The NCM will visit either in person or via telehealth with the participant up to 4 times while incarcerated, and up to 4 times after release.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Plans to reside in Wisconsin after release
* Eligible for Wisconsin Medicaid and willing to enroll prior to release
* Has a history of one or more of the following: current HIV infection, current or past HCV infection, identified need for substance use related services based on Correctional Offender Management Profiling for Alternative Sanctions (COMPAS) assessment
* Anticipated release date (must be within 6 months of review)
Exclusion Criteria
* Planned discharge to another correctional facility or other carceral setting (e.g. release to jail or immigration detention center)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ryan Westergaard, MD, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
UW School of Medicine and Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oakhill Correctional Institution
Oregon, Wisconsin, United States
Robert E. Ellsworth Correctional Center
Union Grove, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0398
Identifier Type: -
Identifier Source: org_study_id
Protocol Version 6/9/2024
Identifier Type: OTHER
Identifier Source: secondary_id
A534265
Identifier Type: OTHER
Identifier Source: secondary_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.